Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Endometrial cancer.

Frederic Amant1, Philippe Moerman, Patrick Neven

  • 1Department of Obstetrics and Gynaecology, Division of Gynaecological Oncology, UZ Gasthuisberg, Katholieke Universiteit, Leuven, Belgium.

Lancet (London, England)
|August 9, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reply of the authors: 'Transvaginal ultrasound as a guiding tool in the management for deep endometriosis'.

Fertility and sterility·2026
Same author

Image-guided brachytherapy in patients with inoperable FIGO 2009 stage IVB endometrial cancer who were not candidates for palliative surgery.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2026
Same author

Correlation between ultrasound and gross pathology examination of malignant ovarian tumors: a pictorial review for pattern recognition.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2026
Same author

Diagnostic tests for ovarian cancer in premenopausal women with non-specific symptoms (ROCkeTS): prospective, multicentre, cohort study.

BMJ (Clinical research ed.)·2026
Same author

Ultrasound as a noninvasive diagnostic tool to detect deep endometriosis using the International Deep Endometriosis Analysis terminology.

Fertility and sterility·2025
Same author

Evaluation of performance measures in predictive artificial intelligence models to support medical decisions: overview and guidance.

The Lancet. Digital health·2025
Same journal

Inherited retinal degenerations: clinical phenotypes and emerging therapies.

Lancet (London, England)·2026
Same journal

Documenting hospice care.

Lancet (London, England)·2026
Same journal

After the wood chipper.

Lancet (London, England)·2026
Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026
Same journal

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Lancet (London, England)·2026
Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026
See all related articles

Endometrial cancer affects many women globally, with survival rates around 80%. Early detection and understanding histological types are key for effective treatment and improved outcomes in this common gynecologic cancer.

Area of Science:

  • Gynecologic Oncology
  • Cancer Epidemiology

Background:

  • Endometrial cancer impacts approximately 142,000 women annually worldwide, with a significant mortality rate.
  • Incidence peaks in the seventh decade, predominantly post-menopause, though early symptoms often lead to early-stage diagnosis.
  • Overall 5-year survival is approximately 80%, but prognosis varies significantly by histological type.

Purpose of the Study:

  • To provide a comprehensive review of current knowledge on endometrial cancer.
  • To cover epidemiology, pathology, pathogenesis, risk factors, prevention, diagnosis, staging, prognostic factors, treatment, and follow-up.

Main Methods:

  • Review of current scientific literature and clinical concepts.
  • Synthesis of information on various aspects of endometrial cancer management.

Related Experiment Videos

Main Results:

  • Type 1 endometrial cancers are typically hormone-sensitive, low-stage, and have an excellent prognosis.
  • Type 2 tumors are high-grade, prone to recurrence even at early stages, necessitating tailored adjuvant therapies.
  • Surgery is the cornerstone for staging and guiding adjuvant treatment for high-risk patients.

Conclusions:

  • Understanding the distinct prognostic differences between endometrial cancer subtypes is crucial.
  • Personalized treatment strategies, guided by surgical staging and risk stratification, are essential for optimizing patient outcomes.
  • Continued research into risk factors, prevention, and novel therapeutic approaches is vital for reducing the global burden of endometrial cancer.